Literature DB >> 2044908

Distribution of the VLA family of integrins in normal and pathological human liver tissue.

R Volpes1, J J van den Oord, V J Desmet.   

Abstract

The "very late activation" (VLA) subgroup of the integrin superfamily of adhesion molecules plays a central role in cell-cell and cell-matrix interactions. The six different VLA dimers known so far consist of a common beta subunit and a variable alpha (1 to 6) subunit. They serve as receptors for laminin, collagen, and fibronectin or function as adhesion molecules for leukocytes and are therefore of great significance in embryogenesis, growth and repair, and in leukocyte recirculation. The distribution of the common beta and the variable alpha chains of the VLA were studied in normal, inflammatory, and cholestatic liver biopsy samples. In normal liver tissue, vascular endothelia express alpha 1, 2, 3, 5, and 6; bile duct epithelium alpha 2, 3, 5, and 6; connective tissue stroma alpha 1 and 2; hepatocytes alpha 1 and 5; sinusoidal lining cells alpha 1, 2, and 5; and mononuclear cells alpha 4. Whereas bile ducts and vascular endothelia do not show relevant changes in alpha chain expression in liver diseases, hepatocytes de novo express membranous alpha 3 and 6 in inflammatory liver diseases. In view of the role of the VLA-3 and VLA-6 as laminin receptors, this finding is in line with the production of laminin in active liver disease. Moreover, de novo expression of "bile duct type" alpha 2, 3, and 6 on periportal hepatocytes in cholestatic liver disease likely illustrates a phenotypic switch of hepatocytes towards bile duct epithelium during cholestasis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044908     DOI: 10.1016/0016-5085(91)90478-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  27 in total

1.  Liver fibrosis.

Authors:  A D Burt
Journal:  BMJ       Date:  1992-09-05

2.  Extended primary culture of human hepatocytes in a collagen gel sandwich system.

Authors:  Y Kono; S Yang; E A Roberts
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-06       Impact factor: 2.416

3.  Integrins: utility as cell type- and stage-specific markers for hepatocellular carcinoma and cholangiocarcinoma.

Authors:  M Enjoji; H Sakai; M Nakashima; H Nawata
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-01       Impact factor: 2.416

Review 4.  Liver bioengineering: from the stage of liver decellularized matrix to the multiple cellular actors and bioreactor special effects.

Authors:  Mireia Caralt; Enrique Velasco; Angel Lanas; Pedro M Baptista
Journal:  Organogenesis       Date:  2014-08-11       Impact factor: 2.500

5.  Role of platelet-activating factor in pathogenesis of galactosamine-lipopolysaccharide-induced liver injury.

Authors:  Y Komatsu; Y Shiratori; Y Hikiba; N Hashimoto; K Han; T Kawase; H Yoshida; K Okano; M Omata
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

6.  Distribution and quantification of alpha 1-integrin subunit in rat organs.

Authors:  S Voigt; R Gossrau; O Baum; K Löster; W Hofmann; W Reutter
Journal:  Histochem J       Date:  1995-02

7.  Differential expression of laminin receptors in human hepatocellular carcinoma.

Authors:  I Ozaki; K Yamamoto; T Mizuta; S Kajihara; N Fukushima; Y Setoguchi; F Morito; T Sakai
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

8.  Integrins as differential cell lineage markers of primary liver tumors.

Authors:  R Volpes; J J van den Oord; V J Desmet
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

9.  Dysprosium-Modified Tobacco Mosaic Virus Nanoparticles for Ultra-High-Field Magnetic Resonance and Near-Infrared Fluorescence Imaging of Prostate Cancer.

Authors:  He Hu; Yifan Zhang; Sourabh Shukla; Yuning Gu; Xin Yu; Nicole F Steinmetz
Journal:  ACS Nano       Date:  2017-09-06       Impact factor: 15.881

10.  Detection of cell-adhesion molecules on human liver-associated lymphocytes.

Authors:  M Garcìa-Barcina; M Winnock; I Bidaurrazaga; S Huet; P Bioulac-Sage; C Balabaud
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.